Your account is not claimed yet. You can sign up with ORCID to claim your account.

Andrea Gramegna

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Venues

Biomedicines

International journal of molecular sciences

Advances in respiratory medicine

Vaccines

University of Milan

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Milan Feb 1o 2019

Italy

Assistant Professor :: Department of Pathophysiology and Transplantation

Publications

Francesco Amati, Anna Stainer, Veronica Polelli, Marco Mantero, Andrea Gramegna, Francesco Blasi, Stefano Aliberti
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review. International journal of molecular sciences 24 (9) (2023)
Letizia Corinna Morlacchi, Umberto Zanini, Andrea Gramegna, Paola Faverio, Francesco Blasi, Fabrizio Luppi
Idiopathic interstitial pneumonia in a patient with von Hippel-Lindau syndrome: a first case. ERJ open research 9 (6) (2023)
Francesco Amati, Francesco Bindo, Anna Stainer, Andrea Gramegna, Marco Mantero, Mattia Nigro, Linda Bussini, Michele Bartoletti, Francesco Blasi, Stefano Aliberti
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia. Advances in respiratory medicine 91 (3) (2023)
Francesco Amati, Francesco Bindo, Anna Stainer, Andrea Gramegna, Marco Mantero, Mattia Nigro, Linda Bussini, Michele Bartoletti, Francesco Blasi, Stefano Aliberti
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia. Advances in respiratory medicine 91 (3) (2023)
Francesco Amati, Anna Stainer, Veronica Polelli, Marco Mantero, Andrea Gramegna, Francesco Blasi, Stefano Aliberti
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review. International journal of molecular sciences 24 (9) (2023)
Francesco Amati, Francesco Bindo, Anna Stainer, Andrea Gramegna, Marco Mantero, Mattia Nigro, Linda Bussini, Michele Bartoletti, Francesco Blasi, Stefano Aliberti
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia. Advances in respiratory medicine 91 (3) (2023)
Chiara Rosazza, Laura Alagna, Alessandra Bandera, Arianna Biffi, Fabiana Ciciriello, Andrea Gramegna, Vincenzina Lucidi, Paola Giovanna Marchisio, Paola Medino, Antonio Muscatiello, Sara Uceda Renteria, Carla Colombo
Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups. Italian journal of pediatrics 49 (1) (2023)
Francesco Amati, Francesco Bindo, Anna Stainer, Andrea Gramegna, Marco Mantero, Mattia Nigro, Linda Bussini, Michele Bartoletti, Francesco Blasi, Stefano Aliberti
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia. Advances in respiratory medicine 91 (3) (2023)
Francesco Amati, Andrea Gramegna, Martina Contarini, Anna Stainer, Cristina Curcio, Stefano Aliberti, Angelo Guido Corsico, Francesco Blasi
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience. Biomedicines 10 (12) (2022)
Paola Medino, Gianfranco Alicandro, Chiara Rosazza, Fabiana Ciciriello, Andrea Gramegna, Arianna Biffi, Valeria Daccò, Vincenzina Lucidi, Marco Cipolli, Mariaserena Boraso, Erica Nazzari, Carla Colombo
Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes. Biomedicines 10 (11) (2022)
Francesco Amati, Anna Stainer, Marco Mantero, Andrea Gramegna, Edoardo Simonetta, Giulia Suigo, Antonio Voza, Anoop M Nambiar, Umberto Cariboni, Justin Oldham, Philip L Molyneaux, Paolo Spagnolo, Francesco Blasi, Stefano Aliberti
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases. International journal of molecular sciences 23 (2) (2022)
Francesco Amati, Andrea Gramegna, Martina Contarini, Anna Stainer, Cristina Curcio, Stefano Aliberti, Angelo Guido Corsico, Francesco Blasi
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience. Biomedicines 10 (12) (2022)
Marta Marsilio, Andrea Gramegna, Floriana Fusco, Eleonora Gheduzzi, Giovanna Pizzamiglio, Francesco Blasi, Chiara Guglielmetti
The Evaluation of Determinants and Impacts of Co-Production in Healthcare: A Research Protocol for OPAT in Cystic Fibrosis. International journal of integrated care 21 (2) (2021)
Andrea Costantino, Matilde Topa, Leda Roncoroni, Luisa Doneda, Vincenza Lombardo, Davide Stocco, Andrea Gramegna, Claudio Costantino, Maurizio Vecchi, Luca Elli
COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease. Vaccines 9 (5) (2021)
Martina Oriano, Andrea Gramegna, Francesco Amati, Alice D'Adda, Michele Gaffuri, Marco Contoli, Francesco Bindo, Edoardo Simonetta, Carlotta Di Francesco, Martina Santambrogio, Giovanni Sotgiu, Francesco Blasi, Stefano Aliberti
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis. Biomedicines 9 (7) (2021)
Marco Pappalardo, Umberto Fanelli, Vincenzo Chiné, Cosimo Neglia, Andrea Gramegna, Alberto Argentiero, Susanna Esposito
Telemedicine in Pediatric Infectious Diseases. Children (Basel, Switzerland) 8 (4) (2021)
Nicola Principi, Alberto Argentiero, Cosimo Neglia, Andrea Gramegna, Susanna Esposito
New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Andrea Gramegna, Martina Contarini, Stefano Aliberti, Rosaria Casciaro, Francesco Blasi, Carlo Castellani
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis. International journal of molecular sciences 21 (16) (2020)

Andrea Gramegna.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrea Gramegna